Reports for APOTEX INC

Formerly known as AA PHARMA INC

Company Name
APOTEX INC

Shortage reports

Actual shortage:

220 (7%)

Anticipated shortage:

0 (0%)

Avoided shortage:

10 (0%)

Resolved:

3124 (93%)

3354

Discontinuation Reports

To be discontinued:

26 (7%)

Discontinued:

343 (93%)

Reversed:

0 (0%)

369

145 (4%)

73 (30%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-01-26 2023-02-23 182382
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2020-10-28 2021-02-16 127342
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-10-04 2025-01-10 239373
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-09 2023-09-22 194571
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2025-01-30 2025-03-28 249074
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-11-26 2020-12-17 128933
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-26 2024-05-31 217481
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2017-11-21 2018-03-21 29960
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2025-02-06 2025-04-04 249766
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2020-07-29 2020-07-30 121325
APO-GLIMEPIRIDE 4MG TABLET Resolved 2017-11-28 2019-09-21 31007
APO-GLIMEPIRIDE 2MG TABLET Resolved 2018-07-11 2019-09-21 55281
APO-GLIMEPIRIDE 1MG TABLET Resolved 2017-12-12 2019-09-21 32536
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214220
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-08 2024-01-12 212949
APO-GUANFACINE XR 3MG TABLET (EXTENDED-RELEASE) Resolved 2022-06-12 2022-07-28 162475
APO-GUANFACINE XR 2MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-22 2024-01-12 214232
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2022-07-11 2022-08-12 164378
APO-GUANFACINE XR 4MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-15 2024-01-12 213559
Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2019-03-11 2019-03-11 78260
APO-RISPERIDONE 3.0MG TABLET Discontinued 2018-09-08 2019-06-12 60750
APO-RISPERIDONE 1MG SOLUTION To be discontinued 2018-09-08 2018-09-08 60753
APO-RIZATRIPTAN RPD Discontinued 2019-01-04 2019-04-04 71334
APO-RIZATRIPTAN RPD Discontinued 2018-09-08 2019-04-02 60756
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-02-13 60763
APO-ROSUVASTATIN 10MG TABLET Discontinued 2018-09-08 2019-07-13 60758
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2019-02-05 60778
APO-ROSUVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-12-28 60766
APO-ROSUVASTATIN 5MG TABLET Discontinued 2018-09-08 2018-09-15 60775
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-08-08 60772
APO-ROSUVASTATIN 40MG TABLET Discontinued 2018-09-08 2019-02-13 60769
APO-SALVENT TABLETS - 2MG 2MG TABLET Discontinued 2018-02-23 2018-12-28 40854
APO-SALVENT TABLETS - 4MG 4MG TABLET Discontinued 2018-02-23 2018-07-17 40847
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
APO-SILDENAFIL 100MG TABLET Discontinued 2018-09-08 2018-09-15 60784
APO-SILDENAFIL R Discontinued 2018-09-08 2018-09-15 60787
APO-SIMVASTATIN 20MG TABLET Discontinued 2018-09-08 2018-11-19 60793
APO-SIMVASTATIN 10MG TABLET Discontinued 2018-09-08 2018-12-28 60790
APO-SOLIFENACIN 5MG TABLET Discontinued 2019-03-11 2019-09-20 78272